Symphony Q1 FY26 Results: Revenue Falls 39% YoY; ₹1 Interim Dividend Announced

Ahmedabad, August 1, 2025 – Symphony Limited (NSE: SYMPHONY, BSE: 517385) reported a sharp decline in its Q1 FY26 financial performance, as both consolidated and standalone figures demonstrated negative growth rates due to seasonal headwinds and an overall unfavourable base effect. The company also declared an interim dividend of ₹1 per share (FV ₹2), but it did not have much impact on the stock price, which plummeted after the earnings announcement.

Symphony Limited Stock Price Movement

At 01:30 PM, the share traded at ₹1094.70 (1.81% down from the previous day’s closing price). The low-high range of the day remained between ₹1071 and ₹1140. The share plummeted as soon as the company announced the Q1 earnings. After today’s fall, the share price has dropped by more than 13% over the past 6 months. The company’s P/E ratio is 36.17, compared to the industrial average of 66.58.

Financial Highlights

Symphony Ltd reported a sharp decline in Q1 FY26 performance. Consolidated revenue fell 36% YoY to ₹251 crore, while EBITDA dropped 71% to ₹26 crore, with the EBITDA margin contracting from 22.3% to 10.2%. PAT stood at ₹42 crore, down 52% YoY. Standalone figures also reflected similar weakness, with revenue down 39%, EBITDA down 71%, and PAT declining 46%. The drop is attributed to lower sales and compressed margins across operations.

Management Commentary

Mr. Nrupesh Shah, Managing Director (Corporate Affairs) stated, “Despite a rain-impacted summer and a high base from Q1 FY25, Symphony recorded its second-highest ever summer-season standalone revenue. While margins were under pressure, our global subsidiaries demonstrated mixed performance, with GSK China continuing its debt-reduction drive and Symphony Australia marking its second straight quarter of YoY growth.”

Segmental & Strategic Performance

Symphony’s India standalone operations faced seasonal headwinds, leading to lower revenue and EBITDA margins. GSK China repaid ₹27.9 crore of its inter-company loan, reducing the balance to ₹26.1 crore, supported by IP monetisation. IMPCO Mexico’s performance was subdued due to a weak summer. In contrast, Symphony Australia maintained YoY growth, aided by strategic transformation and asset-light expansion. Additionally, GSK China transferred nine IPRs (Intellectual Property Rights) to IMPCO Mexico in a ₹44 crore deal, with ₹22 crore realised in Q1 and the remainder expected in Q2.

Strategic Outlook

Symphony is reinforcing its innovation-driven strategy to lead in both seasonal and counter-seasonal segments. It is scaling up the popular ‘Air Force’ cooler range and diversifying into all-season products like tower and kitchen fans, LSV cooling, and water heaters. The company is also boosting its reach in semi-urban and rural markets through digital and modern trade channels. Globally, Symphony aims to tap high-growth, high-margin regions by adopting an export-led approach.

About Symphony Limited

Symphony Limited is a global leader in air cooling solutions, operating in over 60 countries. Founded in 1988 in Gujarat, the company pioneered evaporative air cooling in India and has since evolved into a multinational brand with strong R&D, disruptive innovations, and a dominant presence in the household, commercial, and industrial cooling segments. Symphony continues to drive product innovation across all-season categories, strengthening its leadership in comfort cooling.

REF: https://nsearchives.nseindia.com/corporate/SYMPHONY_01082025115338_Media_Release_01_08_2025.pdf

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations